Serological survey of SARS-CoV-2 incidence conducted at a rural West Virginia hospital
Alexander M. Horspool,Brynnan P. Russ,M. Allison Wolf,Jason Kang,Catherine B. Blackwood,Jesse M. Hall,Ting Y. Wong,Megan A. DeJong,Graham J. Bitzer,Justin R. Bevere,Robert Eggleston,Anita Stewart,Lisa Costello,Shelly Welch,Theodore Kieffer,Sally Hodder,F. Heath Damron +16 more
Reads0
Chats0
TLDR
In this paper, the authors found a significant negative correlation between date of exposure and degree of anti-SARS-CoV-2 RBD IgG (R2 = 0.9006) and days post exposure.Abstract:
The SARS-CoV-2 pandemic has affected all types of global communities. Differences in urban and rural environments have led to varying levels of transmission within these subsets of the population. To fully understand the prevalence and impact of SARS-CoV-2 it is critical to survey both types of community. This study establishes the prevalence of SARS-CoV-2 in a rural community: Montgomery, West Virginia. Approximately 10% of participants exhibited serological or PCR-based results indicating exposure to SARS-CoV-2 within 6 months of the sampling date. Quantitative analysis of IgG levels against SARS-CoV-2 receptor binding domain (RBD) was used to stratify individuals based on antibody response to SARS-CoV-2. A significant negative correlation between date of exposure and degree of anti-SARS-CoV-2 RBD IgG (R2 = 0.9006) was discovered in addition to a correlation between neutralizing anti-SARS-CoV-2 antibodies (R2 = 0.8880) and days post exposure. Participants were confirmed to have normal immunogenic profiles by determining serum reactivity B. pertussis antigens commonly used in standardized vaccines. No significant associations were determined between anti-SARS-CoV-2 RBD IgG and age or biological sex. Reporting of viral-like illness symptoms was similar in SARS-CoV-2 exposed participants greater than 30 years old (100% reporting symptoms 30-60 years old, 75% reporting symptoms >60 years old) in contrast to participants under 30 years old (25% reporting symptoms). Overall, this axnalysis of a rural population provides important information about the SARS-CoV-2 pandemic in small rural communities. The study also underscores the fact that prior infection with SARS-CoV-2 results in antibody responses that wane over time which highlights the need for vaccine mediated protection in the absence of lasting protection.read more
Citations
More filters
Journal ArticleDOI
Genomics of Alzheimer's disease implicates the innate and adaptive immune systems.
TL;DR: The role of innate and adaptive immunity in late-onset Alzheimer's disease (AD) is investigated in this paper, which suggests that a systemic failure of cell-mediated amyloid-β (Aβ) clearance contributes to AD onset and progression.
References
More filters
Journal ArticleDOI
Antibody responses to SARS-CoV-2 in patients with COVID-19.
Quanxin Long,Bai Zhong Liu,Hai Jun Deng,Gui Cheng Wu,Kun Deng,Yao Kai Chen,Pu Liao,Jing Fu Qiu,Yong Lin,Xue Fei Cai,Deqiang Wang,Yuan Hu,Ji Hua Ren,Ni Tang,Yin Yin Xu,Li Hua Yu,Zhan Mo,Fang Gong,Xiao-li Zhang,Wen Guang Tian,Li Hu,Xian Xiang Zhang,Jiang Lin Xiang,Hong Xin Du,Hua Wen Liu,Chun Hui Lang,Xiao He Luo,Shao Bo Wu,Xiao Ping Cui,Zheng Zhou,Man Man Zhu,Jing Wang,Cheng Jun Xue,Xiao Feng Li,Li Wang,Zhi Jie Li,Kun Wang,Chang Chun Niu,Qing Jun Yang,Xiaojun Tang,Yong Zhang,Xia Mao Liu,Jin Jing Li,De Chun Zhang,Fan Zhang,Liu Ping,Jun Yuan,Qin Li,Jie Li Hu,Juan Chen,Ailong Huang +50 more
TL;DR: It is suggested that SARS-CoV2-specific IgG or IgM seroconversion occurs within 20 days post symptom onset and may be helpful for the diagnosis of suspected patients with negative RT–PCR results and for the identification of asymptomatic infections.
Journal ArticleDOI
Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak.
TL;DR: Public health measures were decisive in controlling the SARS epidemic in 2003 but whether these measures will be sufficient to control 2019-nCoV depends on addressing some unanswered questions.
Journal ArticleDOI
Convergent antibody responses to SARS-CoV-2 in convalescent individuals.
Davide F. Robbiani,Davide F. Robbiani,Christian Gaebler,Frauke Muecksch,Julio C. C. Lorenzi,Zijun Wang,Alice Cho,Marianna Agudelo,Christopher O. Barnes,Anna Gazumyan,Shlomo Finkin,Thomas Hagglof,Thiago Y. Oliveira,Charlotte Viant,Arlene Hurley,Hans Heinrich Hoffmann,Katrina G. Millard,Rhonda G. Kost,Melissa Cipolla,Kristie Gordon,Filippo Bianchini,Spencer T. Chen,Victor A. Ramos,Roshni Patel,Juan Dizon,Irina Shimeliovich,Pilar Mendoza,Harald Hartweger,Lilian Nogueira,Maggi Pack,Jill Horowitz,Fabian Schmidt,Yiska Weisblum,Eleftherios Michailidis,Alison W. Ashbrook,Eric Waltari,John E. Pak,Kathryn E. Huey-Tubman,Nicholas Koranda,Pauline R. Hoffman,Anthony P. West,Charles M. Rice,Theodora Hatziioannou,Pamela J. Bjorkman,Paul D. Bieniasz,Paul D. Bieniasz,Marina Caskey,Michel C. Nussenzweig,Michel C. Nussenzweig +48 more
TL;DR: Most convalescent plasma samples obtained from individuals who recover from COVID-19 do not contain high levels of neutralizing activity, and rare but recurring RBD-specific antibodies with potent antiviral activity were found in all individuals tested, suggesting that a vaccine designed to elicit such antibodies could be broadly effective.
Journal ArticleDOI
COVID-19 pathophysiology: A review.
TL;DR: The current knowledge about this disease is reviewed and the potential explanation of the different symptomatology between children and adults is considered.
Journal ArticleDOI
Age-dependent effects in the transmission and control of COVID-19 epidemics.
TL;DR: It is found that interventions aimed at children might have a relatively small impact on reducing SARS-CoV-2 transmission, particularly if the transmissibility of subclinical infections is low.
Related Papers (5)
Community SARS-CoV-2 seroprevalence before and after the second wave of SARS-CoV-2 infection in Harare, Zimbabwe.
Arun Fryatt,Victoria Simms,Victoria Simms,Tsitsi Bandason,Nicol Redzo,Ioana D. Olaru,Ioana D. Olaru,Chiratidzo E. Ndhlovu,Hilda Mujuru,Simbarashe Rusakaniko,Michael Hoelscher,Raquel Rubio-Acero,Ivana Paunovic,Andreas Wieser,Prosper Chonzi,Kudzai P.E. Masunda,Rashida A. Ferrand,Rashida A. Ferrand,Katharina Kranzer,Katharina Kranzer,Katharina Kranzer +20 more